CNS Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • CNS Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$2.62K, a 163% decline year-over-year.
  • CNS Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $12.7K.
  • CNS Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $13.9K.
  • CNS Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$7.03K, a 24.3% increase from 2021.
  • CNS Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$9.29K, a 184% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.9K +$20.9K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$7.03K +$2.26K +24.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$9.29K -$6.02K -184% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$3.26K +$41K +92.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$44.2K +$6.47M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-12
2018 -$6.51M* Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.